Category: New products
-
Stem Cells Shown to Regenerate Dental Pulp Tissue
A combination of dental pulp stem cells and cells from human umbilical cords, mixed with a common hydrogel, were shown in lab rats to regenerate pulp-like tissue in teeth roots.
-
New Type of Antibiotic Set for Early Trial
A clinical trial is set to test a type of drug that its developers say is designed to treat infections from bacteria resistant to earlier antibiotics.
-
Trial to Explore Microbiome Therapy for Hypertension
A clinical trial is set to begin that tests live bacteria as a treatment for hypertension, or high blood pressure, a condition affecting 1 in 3 adults in the U.S.
-
Trial Testing Stem-Cell Implant for Cartilage Repair
An early clinical trial testing implants of a person’s stem cells to repair damaged knee cartilage in younger adults returned largely favorable results.
-
Project to Design Hybrid Stroke Imaging Technology
An alliance of academic and industry researchers in Europe is developing a single imaging device that can save valuable time in diagnosing a stroke.
-
Peptide-Infused Gel Shown to Heal Chronic Wounds
A tissue engineering group developed a gel material infused with a synthetic peptide that in lab cultures and animals healed chronic diabetic wounds faster than a current commercial treatment.
-
Human-Like Soft Touch Robotic Sensors Developed
A robotic hand with built-in sensors that can sense fine differences in shape and texture is being developed in an engineering lab at Cornell University.
-
Engineered T-Cells Tested on Metastatic Cancer
An individual with lung cancer tumors that spread from the colon had the tumors reduced in size after a single treatment of modified cancer-killing immune system cells.
-
Synthetic Insulin-Producing Cells Designed, Tested
Synthetic beta cells, like natural cells in the pancreas, were shown in tests with lab mice to sense glucose levels in the blood and produce insulin.
-
LEDs Shown to Reduce Alzheimer’s Brain Plaques
Pulsating LED lights were shown in lab mice to reduce amyloid-beta plaque deposits associated with Alzheimer’s disease on brain cells, with the lead researchers starting a company to commercialize the technology.